Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

466
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
466
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.2K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.2K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.3K
Dialysis01:27

Dialysis

1.7K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K
Dialysis01:15

Dialysis

2.0K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and Opportunities in Translating Extracellular Vesicles into Clinical Applications.

Stem cells and development·2025
Same author

Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents.

Stem cell reviews and reports·2025
Same author

Stem cells and stem cell-derived extracellular vesicles in acute and chronic kidney diseases: mechanisms of repair.

Annals of translational medicine·2020
Same author

A Versatile Model of Microfluidic Perifusion System for the Evaluation of C-Peptide Secretion Profiles: Comparison Between Human Pancreatic Islets and HLSC-Derived Islet-Like Structures.

Biomedicines·2020
Same author

Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice.

Scientific reports·2020
Same author

HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.

Molecular therapy : the journal of the American Society of Gene Therapy·2019

Related Experiment Video

Updated: Feb 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K

Dialysis patients and cardiovascular problems: can technology solve the complex equation?

Claudio Ronco1, Ciro Tetta

  • 1St. Bortolo Hospital, Department of Nephrology, Viale Rodolfi, 36100, Vicenza, Italy. cronco@goldnet.it

Expert Review of Medical Devices
|November 19, 2005
PubMed
Summary

Patients undergoing chronic hemodialysis have significantly higher mortality, especially from cardiovascular causes. New cardioprotective dialysis therapies and technologies aim to improve patient outcomes and reduce fatal cardiovascular events.

More Related Videos

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
04:36

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

2.7K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K

Related Experiment Videos

Last Updated: Feb 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
04:36

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

2.7K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K

Area of Science:

  • Nephrology
  • Cardiology
  • Biomedical Engineering

Background:

  • End-stage kidney disease (ESKD) patients on chronic hemodialysis face substantially elevated mortality rates.
  • Cardiovascular disease accounts for approximately 50% of deaths in hemodialysis patients, with risks 10- to 30-times higher than the general population.
  • Cardiovascular burden in these patients stems from uremic syndrome, traditional risk factors, and dialysis-related factors.

Purpose of the Study:

  • To explore the development of 'cardioprotective dialysis therapy' to mitigate cardiovascular risks in hemodialysis patients.
  • To highlight the role of innovative dialysis technologies and machines in enhancing patient safety and treatment efficacy.

Main Methods:

  • Review of existing literature on cardiovascular risks in hemodialysis patients.
  • Analysis of how dialysis procedures and patient-specific factors contribute to cardiovascular burden.
  • Introduction of new technological advancements in dialysis machines and online hemodiafiltration.

Main Results:

  • Hemodialysis patients exhibit a markedly increased risk of cardiovascular death.
  • Cardiovascular complications are multifactorial, involving patient-inherent risks and dialysis-related influences.
  • Emerging technologies offer potential for improved dialysis tolerance and cardiovascular event protection.

Conclusions:

  • A 'cardioprotective dialysis therapy' approach is crucial for improving survival in ESKD patients.
  • Advancements in dialysis technology, such as enhanced monitoring and online hemodiafiltration, can lead to better cardiovascular protection.
  • Optimizing dialysis protocols and technology is essential to reduce the high incidence of fatal cardiovascular events in this vulnerable population.